If validated in larger studies, deep brain stimulation will become the first clinically proven therapy to slow Parkinson's disease progression

New data chronicling the long-term effects of deep brain stimulation (DBS) on early-stage Parkinson’s disease patients has found the treatment significantly slows its progression. Researchers from Vanderbilt University Medical Center suggest, if the results are validated in a large Phase 3 trial currently underway, DBS will become the first therapy clinically proven to slow the progression of this neurodegenerative disease.

Continue Reading

Category: Medical, Science

Tags: , , , , , ,